Chris Hoyle is an experienced professional in health economics and market access, currently serving as the Head of Market Access, Pricing & HEOR at Immunocore. They have previously held prominent positions at AstraZeneca, where they directed payer and HTA policy, and at MSD, focusing on HTA submissions and economic model development. Chris earned a PhD in Biochemistry from the University of Leeds, as well as a Master's Degree in Economic Evaluation in Healthcare with distinction from City University. Their diverse background includes a significant role in commercializing bioanalytical technology at Eksigent Technologies and contributions to health economics consulting at the Office of Health Economics.
This person is not in any teams
This person is not in any offices